RecruitingPhase 4NCT07382596

Cervical Plexus Hydrodissection With D5W Versus NS for Treatment-Resistant PTSD


Sponsor

Dr. Dean Reeves Clinic

Enrollment

50 participants

Start Date

May 16, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

PTSD is a chronic mental health condition that drastically reduces an individual's quality of life Dextrose injection with a small needle has been used for chronic pain patients and observational results have shown it to be effective in reducing anxiety, brain fog, and depression in patients with PTSD. This randomized trial will compare dextrose injection with an injection control of normal saline (NS)


Eligibility

Min Age: 19 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Dextrose 5% in water bilateral injection and a drug called Normal saline bilateral injection for people with ptsd. The study is currently recruiting participants at 4 locations. People eligible for this study include aged 19 Years to 90 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDextrose 5% in water bilateral injection

Injection under the investing fascia of the sternocleidomastoid muscle

DRUGNormal saline bilateral injection

Injection under the investing fascia of the sternocleidomastoid muscle


Locations(4)

Wellward Medical

Lexington, Kentucky, United States

NW Regen

Portland, Oregon, United States

Paul Johnson, MD.

Portland, Oregon, United States

Medical Procedures of Wisconsin

Madison, Wisconsin, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07382596


Related Trials